{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:15:36Z","timestamp":1789348536610,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1492-9","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T10:19:15Z","timestamp":1513937955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis"],"prefix":"10.1186","volume":"19","author":[{"given":"L.","family":"Ouboussad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M. A.","family":"Hensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8962-5642","authenticated-orcid":false,"given":"M. H.","family":"Buch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"key":"1492_CR1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","volume":"71","author":"DM Gerlag","year":"2012","unstructured":"Gerlag DM, Raza K, van Baarsen LG, Brouwer E, Buckley CD, Burmester GR, et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis. 2012;71:638\u201341.","journal-title":"Ann Rheum Dis."},{"key":"1492_CR2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/ard.2009.126821","volume":"70","author":"L Padyukov","year":"2010","unstructured":"Padyukov L, Seielstad M, Ong RT, Ding B, R\u00f6nnelid J, Seddighzadeh M, et al. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis. 2010;70:259\u201365.","journal-title":"Ann Rheum Dis."},{"key":"1492_CR3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","volume":"50","author":"F Gaalen Van","year":"2004","unstructured":"Van Gaalen F, Linn-Rasker S, Van Venrooij W, De Jong B, Breedveld F, Verweij C, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 2004;50:709\u201315.","journal-title":"Arthritis Rheum."},{"key":"1492_CR4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrrheum.2014.82","volume":"10","author":"L Hunt","year":"2014","unstructured":"Hunt L, Emery P. Defining populations at risk of rheumatoid arthritis: the first steps to prevention. Nat Rev Rheumatol. 2014;10:521\u201330.","journal-title":"Nat Rev Rheumatol."},{"key":"1492_CR5","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/annrheumdis-2014-205227","volume":"74","author":"C Rakieh","year":"2015","unstructured":"Rakieh C, Nam JL, Hunt L, Hensor EMA, Das S, Bissell L-A, et al. Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Ann Rheum Dis. 2015;74:1659\u201366.","journal-title":"Ann Rheum Dis."},{"key":"1492_CR6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrm1644","volume":"6","author":"VN Kim","year":"2005","unstructured":"Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6:376\u201385.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1492_CR7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","volume":"58","author":"J Stanczyk","year":"2008","unstructured":"Stanczyk J, Pedrioli DML, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, et al. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58:1001\u20139.","journal-title":"Arthritis Rheum."},{"key":"1492_CR8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/art.23429","volume":"58","author":"T Nakasa","year":"2008","unstructured":"Nakasa T, Miyaki S, Okubo A, Hashimoto M, Nishida K, Ochi M, et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008;58:1284\u201392.","journal-title":"Arthritis Rheum."},{"key":"1492_CR9","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1136\/annrheumdis-2015-208235","volume":"75","author":"JL Nam","year":"2016","unstructured":"Nam JL, Hensor EMA, Hunt L, Conaghan PG, Wakefield RJ, Emery P. Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis. Ann Rheum Dis. 2016;75:2060\u20137.","journal-title":"Ann Rheum Dis."},{"key":"1492_CR10","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/nar\/gkr1099","volume":"40","author":"DM Bolser","year":"2012","unstructured":"Bolser DM, Chibon PY, Palopoli N, Gong S, Jacob D, Del Angel VD, et al. MetaBase\u2013the wiki-database of biological databases. Nucleic Acids Res. 2012;40:1250\u20134.","journal-title":"Nucleic Acids Res."},{"key":"1492_CR11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-60761-863-8_16","volume":"676","author":"SJ Chen","year":"2011","unstructured":"Chen SJ, Chen HC. Analysis of targets and functions coregulated by microRNAs. Methods Mol Biol. 2011;676:225\u201341.","journal-title":"Methods Mol Biol."},{"key":"1492_CR12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4:287\u201391.","journal-title":"Pharm Stat."},{"key":"1492_CR13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.autrev.2015.07.005","volume":"14","author":"AV Churov","year":"2015","unstructured":"Churov AV, Oleinik EK, Knip M. MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential. Autoimmun Rev. 2015;14:1029\u201337.","journal-title":"Autoimmun Rev."},{"key":"1492_CR14","first-page":"2143","volume":"149","author":"GS Firestein","year":"1996","unstructured":"Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol. 1996;149:2143\u201351.","journal-title":"Am J Pathol."},{"key":"1492_CR15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/art.38142","volume":"66","author":"J Lin","year":"2014","unstructured":"Lin J, Huo R, Xiao L, Zhu X, Xie J, Sun S, et al. A novel p53\/microRNA\u201022\/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheum. 2014;66:49\u201359.","journal-title":"Arthritis Rheum."},{"key":"1492_CR16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.2010.132662","volume":"70","author":"LA Stadt van de","year":"2011","unstructured":"van de Stadt LA, van der Horst AR, de Koning MH, Bos WH, Wolbink GJ, van de Stadt RJ, et al. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis. 2011;70:128\u201333.","journal-title":"Ann Rheum Dis."},{"key":"1492_CR17","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.27294","volume":"62","author":"LG Baarsen van","year":"2010","unstructured":"van Baarsen LG, Bos WH, Rustenburg F, van der Pouw Kraan TC, Wolbink GJJ, Dijkmans BA, et al. Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis. Arthritis Rheum. 2010;62:694\u2013704.","journal-title":"Arthritis Rheum."},{"key":"1492_CR18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.38273","volume":"66","author":"M Hair","year":"2014","unstructured":"Hair M, Sande M, Ramwadhdoebe T, Hansson M, Landewe R, Leij C, et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheum. 2014;66:513\u201322.","journal-title":"Arthritis Rheum."},{"key":"1492_CR19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/annrheumdis-2012-202753","volume":"72","author":"J L\u00fcbbers","year":"2013","unstructured":"L\u00fcbbers J, Brink M, van de Stadt LA, Vosslamber S, Wesseling JG, van Schaardenburg D, et al. The type I IFN signature as a biomarker of preclinical rheumatoid arthritis. Ann Rheum Dis. 2013;72:776\u201380.","journal-title":"Ann Rheum Dis."},{"key":"1492_CR20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/tpj.2015.30","volume":"16","author":"S Krintel","year":"2015","unstructured":"Krintel S, Dehlendorff C, Hetland M, H\u00f8rslev-Petersen K, Andersen K, Junker P, et al. Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis. Pharmacogenomics J. 2015;16:141\u20136.","journal-title":"Pharmacogenomics J."},{"key":"1492_CR21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13075-016-1085-z","volume":"18","author":"BV Cuppen","year":"2016","unstructured":"Cuppen BV, Rossato M, Fritsch-Stork RD, Concepcion AN, Schenk Y, Bijlsma JW, et al. Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis? Arthritis Res Ther. 2016;18:189.","journal-title":"Arthritis Res Ther."}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1492-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T10:19:25Z","timestamp":1513937965000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1492-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1492"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1492-9","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"288"}}